Beam Therapeutics Inc.BEAMNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 52 | 61 | 378 |
| Gross Profit | -180 | -251 | 378 |
| Operating Income | -392 | -338 | -176 |
| Net Income | -371 | -289 | -133 |
| EBITDA | -230 | -324 | -147 |
| EPS Diluted | -5.77 | -4.13 | -1.72 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 560 | 233 | 436 |
| Total Current Assets | 1,273 | 1,093 | 1,211 |
| Total Assets | 1,474 | 1,342 | 1,460 |
| Total Current Liabilities | 213 | 224 | 206 |
| Total Liabilities | 648 | 608 | 478 |
| Total Equity | 827 | 733 | 981 |
| Total Debt | 148 | 179 | 173 |
| Net Debt | -412 | -54 | -263 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -66 | 23 | -149 |
| Capital Expenditure | -47 | -49 | -34 |
| Free Cash Flow | -113 | -26 | -183 |
| Stock-Based Comp | 44 | 84 | 99 |
| Net Change in Cash | 396 | -327 | 199 |